mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.07 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.07 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.077 |
0.07 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.07 |